A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

NCT00512863 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
272
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott